

Advancements in Therapeutic Research and Mining Projects Unveiled
About this episode
InFlectis BioScience and Aix Marseille Université show promise in treating axonal forms of Charcot-Marie-Tooth Disease with IFB-088, seeking partnerships for clinical trials. Norsemont Mining Inc. secures funds for drilling at the Choquelimpie project, aiming to unlock its potential. Sigyn Therapeutics, Inc. plans a clinical study for Sigyn Therapy™ in high-risk cardiovascular disease subjects. Giant Mining Corp. launches Phase 2 Exploration Program at the Majuba Hill project in Nevada, leveraging AI technology to tap into the region's copper potential.
Comments
Rate this episode
Episode Details
- Author
- NewsRamp
- Show Type
- full
- Audio Format
- audio/mpeg